GUDIDData
gudid Primary ID: 34-2264-51

ImmunoCAP IgE/ECP/Tryptase Sample Diluent (UDI 34-2264-51)

Manufactured by Phadia AB

Data verified against official FDA/EUDAMED records on
Scannable UDI-DI Representation
GS1-128 UDI Barcode representation for ImmunoCAP IgE/ECP/Tryptase Sample Diluent - Primary ID 34-2264-51

Device Regulatory Overview

The ImmunoCAP IgE/ECP/Tryptase Sample Diluent (Model/Catalog Number: 34-2264-51) is a medical device manufactured by Phadia AB. This product is indexed under FDA Product Code / Category Classification DGC within international Unique Device Identification (UDI) compliance databases.

Technical Specifications

Model Number
34-2264-51
Product Code / EMDN
DGC
Device Name
ImmunoCAP IgE/ECP/Tryptase Sample Diluent
Database Sync Date
2026-08-09 09:48:59

Full Regulatory Attributes

🔒 Token Gated
{
    "review_panel": "AN",
    "gudid_di_status": "Published",
    "sterilization_methods": ["EO", "Gamma"],
    "rx_only": true
}
                            

Unlock Compliance Data & Serialization Specs

Access raw JSON payloads, UDI-DI packaging hierarchies, and Notified Body IDs.

Get API Token Access ($49/mo)

Frequently Asked Questions

Who is the primary manufacturer of ImmunoCAP IgE/ECP/Tryptase Sample Diluent?

The registered manufacturer of record for ImmunoCAP IgE/ECP/Tryptase Sample Diluent is Phadia AB.

What is the Primary UDI-DI identifier for ImmunoCAP IgE/ECP/Tryptase Sample Diluent?

The Primary UDI-DI identifier registered in FDA GUDID and EUDAMED records is 34-2264-51.

What classification code is assigned to this device?

This device is registered under product classification code DGC.

Programmatic Export

Export this master device record as standardized JSON or CSV for compliance audits.

JSON API Endpoint